DNA Testing and Diagnostics Market Size, Share, Trends, Growth Outlook

The Global DNA Testing and Diagnostics Market Size is estimated to register 4.8% growth over the forecast period from 2023 to 2030.

 

The market growth is driven by an increasing interest in personalized medicine is driving the demand for DNA testing and diagnostics. Genetic information is used to tailor treatments and therapies to individual patients. Leading Companies focusing on Advancements in Technology, Wider Clinical Integration, Preventive Healthcare, Pharmacogenomics and Drug Development, Environmental DNA (eDNA) Testing, Agriculture and Veterinary Applications, and others to boost market shares in the industry.

 

 

Market Overview

The DNA testing and diagnostics market is a rapidly evolving sector with various applications, including medical diagnostics, ancestry and genealogy, forensic analysis, agriculture, and environmental monitoring. Key players encompass diagnostic laboratories, biotechnology companies, and direct-to-consumer testing firms, while applications range from personalized medicine to gene editing and gene therapy. Market drivers include the growing demand for personalized medicine, consumer interest in direct-to-consumer genetic testing, medical advancements, and technological improvements in DNA sequencing. This dynamic market's future scope is promising, driven by ongoing technological advancements, wider clinical integration, and the expansion of genomics into various industries, such as agriculture and veterinary medicine.

Market Dynamics

Market Trends- Direct-to-consumer (DTC) genetic testing is a type of genetic testing that is marketed directly to consumers, without the need for a doctor's referral.

Direct-to-consumer (DTC) genetic testing has revolutionized healthcare accessibility by allowing consumers to access genetic testing without a doctor's referral. Companies like 23andMe and AncestryDNA offer tests for ancestry, health risks, and wellness insights, making this market segment increasingly popular. However, concerns about privacy and data security, as well as the accurate interpretation of complex genetic information, have emerged, leading to evolving regulatory oversight and guidelines to ensure the ethical use of genetic data and maintain consumer trust.

 

Market Driver- Agricultural and veterinary DNA testing is a growing segment of the DNA testing and diagnostics market, driven by the need to improve the quality and productivity of livestock and crops.

Agricultural and veterinary DNA testing is a rapidly expanding segment of the DNA testing and diagnostics market, driven by the imperative to enhance livestock and crop quality and productivity. It plays a critical role in ensuring healthier, disease-resistant livestock and improved crop yields, thus meeting the growing demand for sustainable farming practices and food security. This surge highlights the pivotal role of DNA testing technology in revolutionizing modern agriculture.

 

Market Opportunity- The introduction of environmental DNA (eDNA) testing is revolutionizing the DNA testing and diagnostics market, enabling the detection and monitoring of species and pathogens in the environment without the need to capture or sample individual organisms.

Environmental DNA (eDNA) testing is revolutionizing the DNA testing and diagnostics market by enabling the non-invasive detection and monitoring of species and pathogens in the environment, eliminating the need for capturing or sampling individual organisms. This breakthrough technology has broad applications in ecological research, biodiversity conservation, and disease surveillance, offering an efficient and cost-effective approach. The market is increasingly embracing eDNA testing, highlighting its pivotal role in advancing environmental science and conservation.

 

Market Share Analysis- NGS DNA Diagnosis DNA Testing and Diagnostics Market will register the fastest growth

The Global DNA Testing and Diagnostics Market is analyzed across NGS DNA Diagnosis, Microarrays-based Diagnostics, PCR-based Diagnostics, In-situ Hybridization Diagnostics, and others. NGS DNA Diagnosis is poised to register the fastest growth. Next-Generation Sequencing (NGS) is a transformative technology within the DNA testing and diagnostics market, enabling high-throughput and precise DNA analysis for clinical diagnostics, genetic research, and personalized medicine. Its rapid sequencing capabilities facilitate accurate disease diagnosis and treatment customization, driving substantial growth in the market and advancing healthcare and genomics research.

 

Market Share Analysis- Cancer Genetics Tests held a significant market share in 2023

The Global DNA Testing and Diagnostics Market is analyzed across various applications including Cancer Genetics Tests, Infectious Diseases DNA Testing, Newborn Genetic Screening, Preimplantation and Reproductive Diagnosis, Non-Infectious Diseases DNA Testing, Prenatal DNA Carrier Screening, Pharmacogenomics, Hematology and Immunology, and others. Of these, Cancer Genetics Tests held a significant market share in 2023. Cancer genetics tests are a crucial part of the DNA testing and diagnostics market, providing personalized insights into an individual's cancer risk based on their genetic makeup. These tests enable early detection and personalized treatment strategies, playing a pivotal role in the shift toward precision medicine. This sector's growth is reshaping cancer care by promoting proactive and targeted approaches to cancer prevention and treatment.

 

DNA Testing and Diagnostics Market Segmentation

By Type

• Microarrays-based Diagnostics
• PCR-based Diagnostics
• In-situ Hybridization Diagnostics
• NGS DNA Diagnosis

By Application

• Cancer Genetics Tests
• Infectious Diseases DNA Testing
• Newborn Genetic Screening
• Preimplantation and Reproductive Diagnosis
• Non-Infectious Diseases DNA Testing
• Prenatal DNA Carrier Screening
• Pharmacogenomics
• Hematology and Immunology
• Others

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

 

DNA Testing and Diagnostics Market Companies

• Abbott Laboratories
• GE Healthcare
• 454 Life Sciences
• Beckman Coulter
• Bio-Rad Laboratories
• Thermo Fisher Scientific
• Cephide
• Hologic
• Transgenomic
• Illumina
• Siemens Healthcare
• Agilent Technologies
• Qiagen
• Affymetrix
• Roche Diagnostics

 

*List not exhaustive

 

DNA Testing and Diagnostics Market Outlook 2023

1 Market Overview

1.1 Introduction to the DNA Testing and Diagnostics Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 DNA Testing and Diagnostics Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global DNA Testing and Diagnostics Market Companies with Area Served

4.2.2 Products Offerings Global DNA Testing and Diagnostics Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 post-COVID-19 Scenario- Low Growth Case

5.1.3 post-COVID-19 Scenario- Reference Growth Case

5.1.4 post-COVID-19 Scenario- Low Growth Case

 

6 Global DNA Testing and Diagnostics Market Trends

6.1 Global DNA Testing and Diagnostics Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global DNA Testing and Diagnostics Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global DNA Testing and Diagnostics Revenue (USD Million) and CAGR (%) by regions (2018-2030)

 

7 Global DNA Testing and Diagnostics Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global DNA Testing and Diagnostics Revenue (USD Million) by Type (2018-2022)

7.1.1 Global DNA Testing and Diagnostics Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global DNA Testing and Diagnostics Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global DNA Testing and Diagnostics Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global DNA Testing and Diagnostics Development Regional Status and Outlook

8.1 Global DNA Testing and Diagnostics Revenue (USD Million) By Regions (2018-2022)

8.2 North America DNA Testing and Diagnostics Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America DNA Testing and Diagnostics Revenue (USD Million) by Country (2018-2022)

8.2.2 North America DNA Testing and Diagnostics Revenue (USD Million) by Type (2018-2022)

8.2.3 North America DNA Testing and Diagnostics Revenue (USD Million) by Applications (2018-2022)

8.3 Europe DNA Testing and Diagnostics Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe DNA Testing and Diagnostics Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe DNA Testing and Diagnostics Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe DNA Testing and Diagnostics Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) by Applications (2018-2022)

8.5 South America DNA Testing and Diagnostics Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America DNA Testing and Diagnostics Revenue (USD Million), by Country (2018-2022)

8.5.2 South America DNA Testing and Diagnostics Revenue (USD Million) by Type (2018-2022)

8.5.3 South America DNA Testing and Diagnostics Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global DNA Testing and Diagnostics Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global DNA Testing and Diagnostics Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global DNA Testing and Diagnostics Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global DNA Testing and Diagnostics Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global DNA Testing and Diagnostics Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global DNA Testing and Diagnostics Development Regional Status and Outlook Forecast

11.1 Global DNA Testing and Diagnostics Revenue (USD Million) By Regions (2023-2030)

11.2 North America DNA Testing and Diagnostics Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America DNA Testing and Diagnostics Revenue (USD) Million by Country (2023-2030)

11.2.2 North America DNA Testing and Diagnostics Revenue (USD Million), by Type (2023-2030)

11.2.3 North America DNA Testing and Diagnostics Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe DNA Testing and Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe DNA Testing and Diagnostics Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe DNA Testing and Diagnostics Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe DNA Testing and Diagnostics Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million), by Applications (2023-2030)

11.5 South America DNA Testing and Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America DNA Testing and Diagnostics Revenue (USD Million), by Country (2023-2030)

11.5.2 South America DNA Testing and Diagnostics Revenue (USD Million), by Type (2023-2030)

11.5.3 South America DNA Testing and Diagnostics Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million), by region (2023-2030)

11.6.2 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global DNA Testing and Diagnostics Market Companies with Areas Served

Table 3 Products Offerings Global DNA Testing and Diagnostics Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global DNA Testing and Diagnostics Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global DNA Testing and Diagnostics Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global DNA Testing and Diagnostics Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 11 Global DNA Testing and Diagnostics Revenue Market Share (%) By Type (2018-2022)

Table 12 Global DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 13 Global DNA Testing and Diagnostics Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global DNA Testing and Diagnostics Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global DNA Testing and Diagnostics Market Share (%) By Regions (2018-2022)

Table 16 North America DNA Testing and Diagnostics Revenue (USD Million) By Country (2018-2022)

Table 17 North America DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 18 North America DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe DNA Testing and Diagnostics Revenue (USD Million) By Country (2018-2022)

Table 20 Europe DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 21 Europe DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 25 South America DNA Testing and Diagnostics Revenue (USD Million) By Country (2018-2022)

Table 26 South America DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 27 South America DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 33 Global DNA Testing and Diagnostics Revenue Market Share (%) By Type (2023-2030)

Table 34 Global DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 35 Global DNA Testing and Diagnostics Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global DNA Testing and Diagnostics Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America DNA Testing and Diagnostics Revenue (USD)By Country (2023-2030)

Table 38 North America DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 39 North America DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe DNA Testing and Diagnostics Revenue (USD Million) By Country (2023-2030)

Table 41 Europe DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 42 Europe DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 46 South America DNA Testing and Diagnostics Revenue (USD Million) By Country (2023-2030)

Table 47 South America DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 48 South America DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 4 Global DNA Testing and Diagnostics Revenue Market Share (%) By Type (2022)

Figure 5 Global DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global DNA Testing and Diagnostics Revenue Market Share (%) By Applications (2022)

Figure 7 Global DNA Testing and Diagnostics Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global DNA Testing and Diagnostics Market Share (%) By Regions (2022)

Figure 9 North America DNA Testing and Diagnostics Revenue (USD Million) By Country (2018-2022)

Figure 10 North America DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 11 North America DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe DNA Testing and Diagnostics Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America DNA Testing and Diagnostics Revenue (USD Million) By Country (2018-2022)

Figure 19 South America DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 20 South America DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 25 Global DNA Testing and Diagnostics Revenue Market Share (%) By Type (2030)

Figure 26 Global DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global DNA Testing and Diagnostics Revenue Market Share (%) By Applications (2030)

Figure 28 Global DNA Testing and Diagnostics Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America DNA Testing and Diagnostics Revenue (USD Million) By Country (2023-2030)

Figure 30 North America DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 31 North America DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe DNA Testing and Diagnostics Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America DNA Testing and Diagnostics Revenue (USD Million) By Country (2023-2030)

Figure 39 South America DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 40 South America DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa DNA Testing and Diagnostics Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches for This Report

Figure 46 Data Triangulation

 

DNA Testing and Diagnostics Market Segmentation

By Type

• Microarrays-based Diagnostics
• PCR-based Diagnostics
• In-situ Hybridization Diagnostics
• NGS DNA Diagnosis

By Application

• Cancer Genetics Tests
• Infectious Diseases DNA Testing
• Newborn Genetic Screening
• Preimplantation and Reproductive Diagnosis
• Non-Infectious Diseases DNA Testing
• Prenatal DNA Carrier Screening
• Pharmacogenomics
• Hematology and Immunology
• Others

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)